Baseline NT‐proBNP Accurately Predicts Symptom Response to Transcatheter Aortic Valve Implantation

BACKGROUND: Up to 30% of patients undergoing transcatheter aortic valve implantation (TAVI) experience minimal symptomatic benefit or die within 1 year, indicating an urgent need for enhanced patient selection. Previous analyses of baseline NT‐proBNP (N‐terminal pro‐brain natriuretic peptide) and TA...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Am Heart Assoc
Asıl Yazarlar: Allen, Christopher J., Joseph, Jubin, Patterson, Tiffany, Hammond‐Haley, Matthew, McConkey, Hannah Z. R., Prendergast, Bernard D., Marber, Michael, Redwood, Simon R.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2020
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7763793/
https://ncbi.nlm.nih.gov/pubmed/33241754
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.120.017574
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller